title: Changes in brain functional connectivity after chronic haloperidol in rats: a network analysis.
abstract: Although the effects of haloperidol (HAL) have been extensively examined in experimental animals at the cellular and brain regional levels, the effects of prolonged HAL treatment on functional connectivity in the brain have not yet been addressed. Here we used expression of the immediate early gene zif268 as a marker of neural activity to examine changes in brain regional interactivity after 12 wk of HAL treatment in rats. zif268 expression was measured by in situ hybridization in 83 brain regions of HAL- and vehicle (VEH)-treated controls and correlations among all brain regions were computed separately for the two treatment groups. The strongest correlations in each group were used for network construction. It was found that VEH and HAL networks were equally segregated and integrated, and that both networks display small world organization. Compared to the VEH network, the HAL network showed enhanced interactivity between the dorsolateral striatum and thalamus, and between different subdivisions of the thalamus. It will be of interest to determine the extent to which the observed changes in functional connectivity may be related to dyskinesias, to changes in motivated behaviours and/or to the therapeutic effects of chronic HAL. By identifying the connectivity features of a chronic HAL network in the absence of other manipulations, the current findings may provide a reference signature pattern to be targeted in future efforts to discriminate between the neural bases of different behavioural outcomes arising from chronic HAL treatment.
authors: Research Imaging Centre, Centre for Addiction and Mental Health,Canada.
authors: Anne L
authors: AL
authors: Wheeler
authors: Behavioural Neurobiology Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health,Canada.
authors: Meaghan C
authors: MC
authors: Creed
authors: Research Imaging Centre, Centre for Addiction and Mental Health,Canada.
authors: Aristotle N
authors: AN
authors: Voineskos
authors: Research Imaging Centre, Centre for Addiction and Mental Health,Canada.
authors: José N
authors: JN
authors: Nobrega
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D051766:Early Growth Response Protein 1 / Q000096:biosynthesis; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009434:Neural Pathways / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D013788:Thalamus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*
chemical_list: D014150:Antipsychotic Agents; D015415:Biomarkers; D051766:Early Growth Response Protein 1; C486110:Egr1 protein, rat; D006220:Haloperidol